Connor, Clark & Lunn Investment Management Ltd. Mirum Pharmaceuticals, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $20 Billion
- Q4 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 176,960 shares of MIRM stock, worth $8.42 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
176,960
Previous 67,375
162.65%
Holding current value
$8.42 Million
Previous $2.63 Million
178.53%
% of portfolio
0.04%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding MIRM
# of Institutions
211Shares Held
53.8MCall Options Held
2.6KPut Options Held
99.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.57MShares$313 Million16.29% of portfolio
-
Janus Henderson Group PLC London, X04.58MShares$218 Million0.1% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$154 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA2.8MShares$133 Million4.33% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.61MShares$124 Million2.07% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.75B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...